SCHEMBL4386982

SCHEMBL4386982

CCc1c(OCOC)cc(OCOC)c(-c2ccccc2)c1CCCO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.40
GCGR P47871 3/20 0.36
USP7 Q93009 2/20 0.33
TSHR P16473 1/20 0.33
DHODH Q02127 1/20 0.33
ESR1 P03372 2/20 0.32
ESR2 Q92731 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ADORA3 P0DMS8 1/20 0.31
POLB P06746 2/20 0.31
LMNA P02545 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31
LTB4R Q15722 1/20 0.31
LTB4R2 Q9NPC1 1/20 0.31
PDCD1 Q15116 1/20 0.31
CD274 Q9NZQ7 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LTA4H P09960 1/20 0.31
EPHX2 P34913 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4381984 0.92 EGFR (0.41) EGFRGCGRUSP7DHODHESR1
SCHEMBL4386514 0.90 EGFR (0.37) EGFRGCGRUSP7DHODHMEN1
SCHEMBL4378977 0.90 EGFR (0.37) EGFRGCGRUSP7DHODHMEN1
SCHEMBL4381496 0.88 EGFR (0.35) EGFRGCGR
SCHEMBL4385971 0.87 EGFR (0.37) EGFRGCGRUSP7PDCD1CD274
SCHEMBL4387419 0.87 EGFR (0.38) EGFRGCGRUSP7DHODHMEN1
SCHEMBL4379642 0.86 EGFR (0.37) EGFRGCGRUSP7ESR1ESR2
SCHEMBL4388969 0.85 EGFR (0.34) EGFRGCGRMEN1KMT2ALMNA
SCHEMBL4379817 0.85 EGFR (0.40) EGFRGCGRTSHRDHODHMEN1
SCHEMBL4382249 0.84 EGFR (0.38) EGFRGCGRDHODHMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P EGFR 624/4885GCGR 263/4885USP7 413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.